Researchers examined the effect of publicly reporting in-hospital mortality after percutaneous coronary intervention at Massachusetts hospitals from 2003 to 2010. At hospitals that were publicly identified as negative outliers (i.e., they had higher-than-expected mortality rates), the predicted mortality among PCI patients had a relative reduction of 18 percent compared with non-outlier institutions.
These results suggest that an unintended consequence of public reporting of PCI mortality rates may be avoidance of high-risk patients among hospitals with higher mortality rates, according to the study.
More Articles on Quality Reporting:
10 Benefits, Challenges of Using a Common EMR to Track Adverse Events
Patient Safety Tool: Training Tool for Speaking Up About Safety Risks
3 Strategies to Encourage Speaking Up About Patient Safety Risks
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
